Cyclacel Pharmaceuticals Inc (NASDAQ:CYCC)

1.44
Delayed Data
As of May 25
 -0.01 / -0.69%
Today’s Change
1.28
Today|||52-Week Range
4.94
-17.24%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2018
Operating ActivitiesNet Income / Starting Line-2.2M-1.9M-1.9M-1.3M
 
 
 
 
 
Depreciation8.0K8.0K7.0K7.0K
 
 
 
 
 
Total Other Cash Flow66.0K65.0K66.0K81.0K
 
 
 
 
 
Funds From Operations-2.1M-1.8M-1.8M-1.3M
 
 
 
 
 
Funds From/For Other Operating Expenses-1.9M-535.0K422.0K878.0K
 
 
 
 
 
Net Cash Flow - Operating Activities-201.0K-1.2M-2.2M-2.1M
 
 
 
 
 
 
InvestingCapital Expenditures0.00-9.0K-2.0K-22.0K
 
 
 
 
Net Cash Flow Investing0.00-9.0K-2.0K-22.0K
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale977.0K13.7M198.0K0.00
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total-51.0K-50.0K-50.0K-50.0K
 
 
 
 
 
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing926.0K13.6M148.0K-50.0K
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash137.0K54.0K-41.0K26.0K
 
 
 
 
 
 
Net Change In Cash725.0K12.4M-2.1M-2.2M